Virtus Biotech Clinical Trials ETF
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BBC and other ETFs, options, and stocks.About BBC
BBC tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials.
What's in this fund
Sectors
As of March 30, 2026Top 10 Holdings (16.46% of total assets)
As of March 30, 2026BBC Key Statistics
Stock Snapshot
As of today, Virtus Biotech Clinical Trials ETF(BBC) shares are valued at $42.48. The company's market cap stands at 36.06M, with a P/E ratio of -8.06.
On 2026-04-01, Virtus Biotech Clinical Trials ETF(BBC) stock moved within a range of $42.25 to $42.85. With shares now at $42.48, the stock is trading +0.6% above its intraday low and -0.9% below the session's peak.
Trading volume for Virtus Biotech Clinical Trials ETF(BBC) stock has reached 12.59K, versus its average volume of 18.41K.
The stock's 52-week range extends from a low of $13.42 to a high of $44.10.
The stock's 52-week range extends from a low of $13.42 to a high of $44.10.
Average Annual Return
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.